United States
Securities and Exchange Commission
Washington, D.C. 20549
Form 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended September 30, 20222023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the transition period from _____________________________ to ______________
Commission File Number: 000-20333
NOCOPI TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Maryland | 87-0406496 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
480 Shoemaker Road, Suite 104, King of Prussia, PA 19406
(Address of principal executive offices) (Zip Code)
(610) 834-9600
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None.
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ | Accelerated filer ☐ |
Non-accelerated | Smaller reporting company ☒ |
Emerging growth company ☐ |
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐No☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 2022.2023.
NOCOPI TECHNOLOGIES, INC.
INDEX
i
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements.Statements
Nocopi Technologies, Inc.
Statements of Comprehensive Income*Income (Loss)*
(unaudited)
Three Months ended September 30, | Nine Months ended September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Revenues | ||||||||||||||||
Licenses, royalties and fees | $ | 448,600 | $ | 222,500 | $ | 755,700 | $ | 552,900 | ||||||||
Product and other sales | 237,300 | 90,000 | 783,900 | 884,900 | ||||||||||||
Total revenues | 685,900 | 312,500 | 1,539,600 | 1,437,800 | ||||||||||||
Cost of revenues | ||||||||||||||||
Licenses, royalties and fees | 44,500 | 28,300 | 130,400 | 124,900 | ||||||||||||
Product and other sales | 147,900 | 75,000 | 429,400 | 432,500 | ||||||||||||
Total cost of revenues | 192,400 | 103,300 | 559,800 | 557,400 | ||||||||||||
Gross profit | 493,500 | 209,200 | 979,800 | 880,400 | ||||||||||||
Operating expenses | ||||||||||||||||
Research and development | 23,900 | 44,000 | 95,900 | 134,300 | ||||||||||||
Sales and marketing | 88,900 | 56,600 | 230,400 | 214,000 | ||||||||||||
General and administrative | 180,200 | 122,300 | 964,600 | 385,500 | ||||||||||||
Total operating expenses | 293,000 | 222,900 | 1,290,900 | 733,800 | ||||||||||||
Net income (loss) from operations | 200,500 | (13,700 | ) | (311,100 | ) | 146,600 | ||||||||||
Other income (expenses) | ||||||||||||||||
Interest income | 6,500 | 5,100 | 18,400 | 15,200 | ||||||||||||
Interest expense and bank charges | (500 | ) | (500 | ) | (1,200 | ) | (1,700 | ) | ||||||||
Total other income (expenses) | 6,000 | 4,600 | 17,200 | 13,500 | ||||||||||||
Net income (loss) before income taxes | 206,500 | (9,100 | ) | (293,900 | ) | 160,100 | ||||||||||
Income taxes | — | (10,200 | ) | — | 1,700 | |||||||||||
Net income (loss) | $ | 206,500 | $ | 1,100 | $ | (293,900 | ) | $ | 158,400 | |||||||
Net income (loss) per common share** | ||||||||||||||||
Basic | $ | .03 | $ | .00 | $ | (.04 | ) | $ | .02 | |||||||
Diluted | $ | .03 | $ | .00 | $ | (.04 | ) | $ | .02 | |||||||
Weighted average common shares outstanding** | ||||||||||||||||
Basic | 7,584,512 | 6,751,178 | 7,028,956 | 6,743,324 | ||||||||||||
Diluted | 7,584,512 | 6,751,178 | 7,028,956 | 6,743,324 |
Three Months ended September 30 | Nine Months ended September 30 | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Revenues | ||||||||||||||||
Licenses, royalties and fees | $ | 136,900 | $ | 448,600 | $ | 410,100 | $ | 755,700 | ||||||||
Product and other sales | 438,200 | 237,300 | 1,356,300 | 783,900 | ||||||||||||
Total revenues | 575,100 | 685,900 | 1,766,400 | 1,539,600 | ||||||||||||
Cost of revenues | ||||||||||||||||
Licenses, royalties and fees | 62,700 | 44,500 | 171,200 | 130,400 | ||||||||||||
Product and other sales | 247,300 | 147,900 | 648,300 | 429,400 | ||||||||||||
Total cost of revenues | 310,000 | 192,400 | 819,500 | 559,800 | ||||||||||||
Gross profit | 265,100 | 493,500 | 946,900 | 979,800 | ||||||||||||
Operating expenses | ||||||||||||||||
Research and development | 39,800 | 23,900 | 119,900 | 95,900 | ||||||||||||
Sales and marketing | 71,200 | 88,900 | 218,600 | 230,400 | ||||||||||||
General and administrative | 833,800 | 180,200 | 1,258,300 | 964,600 | ||||||||||||
Total operating expenses | 944,800 | 293,000 | 1,596,800 | 1,290,900 | ||||||||||||
Net income (loss) from operations | (679,700 | 200,500 | (649,900 | ) | (311,100 | ) | ||||||||||
Other income (expenses) | ||||||||||||||||
Interest income | 69,800 | 6,500 | 192,300 | 18,400 | ||||||||||||
Interest expense and bank charges | (4,000 | ) | (500 | ) | (9,000 | ) | (1,200 | ) | ||||||||
Total other income (expenses) | 65,800 | 6,000 | 183,300 | 17,200 | ||||||||||||
Net income (loss) before income taxes | (613,900 | ) | 206,500 | (466,600 | ) | (293,900 | ) | |||||||||
Income taxes | (160,600 | ) | — | (122,700 | ) | — | ||||||||||
Net income (loss) | $ | (453,300 | ) | $ | 206,500 | $ | (343,900 | ) | $ | (293,900 | ) | |||||
Net income (loss) per common share | ||||||||||||||||
Basic | $ | (.05 | ) | $ | .03 | $ | (.04 | ) | $ | (.04 | ) | |||||
Diluted | $ | (.05 | ) | $ | .03 | $ | (.04 | ) | $ | (.04 | ) | |||||
Weighted average common shares outstanding | ||||||||||||||||
Basic | 9,667,845 | 7,584,512 | 9,390,067 | 7,028,956 | ||||||||||||
Diluted | 9,667,845 | 7,584,512 | 9,390,067 | 7,028,956 |
*See accompanying notes to these financial statements.
1 |
Nocopi Technologies, Inc.
Balance Sheets*
(unaudited)
September 30 | December 31 | |||||||
2023 | 2022 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash | $ | 10,476,500 | $ | 5,337,800 | ||||
Accounts receivable less $12,000 allowance for doubtful accounts | 1,357,800 | 1,103,500 | ||||||
Inventory | 384,500 | 486,400 | ||||||
Prepaid and other | 101,200 | 103,300 | ||||||
Total current assets | 12,320,000 | 7,031,000 | ||||||
Fixed assets | ||||||||
Leasehold improvements | 81,500 | 58,400 | ||||||
Furniture, fixtures and equipment | 169,800 | 164,400 | ||||||
Fixed assets, gross | 251,300 | 222,800 | ||||||
Less: accumulated depreciation and amortization | 200,300 | 167,800 | ||||||
Total fixed assets | 51,000 | 55,000 | ||||||
Other assets | ||||||||
Long-term receivable | 1,993,700 | 2,463,100 | ||||||
Operating lease right of use – building | 30,600 | 68,300 | ||||||
Other assets | 2,024,300 | 2,531,400 | ||||||
Total assets | $ | 14,395,300 | $ | 9,617,400 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 97,200 | $ | 97,700 | ||||
Accrued expenses | 233,000 | 173,700 | ||||||
Stock compensation payable | 420,600 | — | ||||||
Income taxes | — | 287,100 | ||||||
Operating lease liability – current | 30,600 | 50,700 | ||||||
Total current liabilities | 781,400 | 609,200 | ||||||
Other liabilities | ||||||||
Accrued expenses – non-current | 139,400 | 172,200 | ||||||
Operating lease liability – non-current | — | 17,600 | ||||||
Total other liabilities | 139,400 | 189,800 | ||||||
Stockholders' equity | ||||||||
Common stock, $ Authorized – shares Issued and outstanding 2023- ; 2022- | par value105,000 | 92,500 | ||||||
Paid-in capital | 21,647,100 | 16,659,600 | ||||||
Accumulated deficit | (8,277,600 | ) | (7,933,700 | ) | ||||
Total stockholders' equity | 13,474,500 | 8,818,400 | ||||||
Total liabilities and stockholders' equity | $ | 14,395,300 | $ | 9,617,400 |
September 30, | December 31, | |||||||
2022 | 2021 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash | $ | 5,355,700 | $ | 1,846,700 | ||||
Accounts receivable less $12,000 allowance for doubtful accounts | 780,000 | 970,800 | ||||||
Inventory | 454,300 | 422,700 | ||||||
Prepaid and other | 95,400 | 160,000 | ||||||
Total current assets | 6,685,400 | 3,400,200 | ||||||
Fixed assets | ||||||||
Leasehold improvements | 58,400 | 58,400 | ||||||
Furniture, fixtures and equipment | 164,900 | 164,100 | ||||||
Fixed assets, gross | 223,300 | 222,500 | ||||||
Less: accumulated depreciation and amortization | 159,700 | 134,200 | ||||||
Total fixed assets | 63,600 | 88,300 | ||||||
Other assets | ||||||||
Long-term receivables | 191,200 | 185,000 | ||||||
Operating lease right of use - building | 80,400 | 115,800 | ||||||
Other assets | 271,600 | 300,800 | ||||||
Total assets | $ | 7,020,600 | $ | 3,789,300 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 38,800 | $ | 3,700 | ||||
Accrued expenses | 176,800 | 151,500 | ||||||
Operating lease liability, current | 49,800 | 47,500 | ||||||
Total current liabilities | 265,400 | 202,700 | ||||||
Other liabilities | ||||||||
Accrued expenses, non-current | 13,200 | 13,000 | ||||||
Operating lease liability, non-current | 30,600 | 68,300 | ||||||
Total other liabilities | 43,800 | 81,300 | ||||||
Stockholders' equity | ||||||||
Common stock, $ Authorized – shares Issued and outstanding** 2022 – ; 2021 – shares | par value92,500 | 67,500 | ||||||
Paid-in capital | 16,659,600 | 13,184,600 | ||||||
Accumulated deficit | (10,040,700 | ) | (9,746,800 | ) | ||||
Total stockholders' equity | 6,711,400 | 3,505,300 | ||||||
Total liabilities and stockholders' equity | $ | 7,020,600 | $ | 3,789,300 |
*See accompanying notes to these financial statements.
2 |
Nocopi Technologies, Inc.
Statements of Cash Flows*
(unaudited)
Nine Months ended September 30, | Nine Months ended September 30 | |||||||||||||||
2022 | 2021 | 2023 | 2022 | |||||||||||||
Operating Activities | ||||||||||||||||
Net income (loss) | $ | (293,900 | ) | $ | 158,400 | $ | (343,900 | ) | $ | (293,900 | ) | |||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities | ||||||||||||||||
Depreciation and amortization | 25,500 | 21,600 | 32,500 | 25,500 | ||||||||||||
Stock based compensation | 420,600 | — | ||||||||||||||
Other assets | 29,200 | 314,500 | 507,100 | 29,200 | ||||||||||||
Other liabilities | (35,200 | ) | (52,800 | ) | (70,500 | ) | (35,200 | ) | ||||||||
Net income adjusted for non-cash operating activities | (274,400 | ) | 441,700 | 545,800 | (274,400 | ) | ||||||||||
(Increase) decrease in assets | ||||||||||||||||
Accounts receivable | 190,800 | 612,400 | (254,300 | ) | 190,800 | |||||||||||
Inventory | (31,600 | ) | (155,600 | ) | 101,900 | (31,600 | ) | |||||||||
Prepaid and other | 64,600 | (32,900 | ) | 2,100 | 64,600 | |||||||||||
Increase (decrease) in liabilities | ||||||||||||||||
Accounts payable and accrued expenses | 60,400 | (26,700 | ) | 58,800 | 60,400 | |||||||||||
Income taxes | — | (36,300 | ) | |||||||||||||
Taxes on income | (287,100 | ) | ||||||||||||||
Total increase in operating capital | 284,200 | 360,900 | (378,600 | ) | 284,200 | |||||||||||
Net cash provided by operating activities | 9,800 | 802,600 | 167,200 | 9,800 | ||||||||||||
Investing Activities | ||||||||||||||||
Additions to fixed assets | (800 | ) | (31,600 | ) | (28,500 | ) | (800 | ) | ||||||||
Net cash used in investing activities | (800 | ) | (31,600 | ) | (28,500 | ) | (800 | ) | ||||||||
Financing Activities | ||||||||||||||||
Issuance of common stock | 3,500,000 | 2,800 | 5,000,000 | 3,500,000 | ||||||||||||
Net cash provided by financing activities | 3,500,000 | 2,800 | 5,000,000 | 3,500,000 | ||||||||||||
Increase in cash | 3,509,000 | 773,800 | ||||||||||||||
Increase (decrease) in cash | 5,138,700 | 3,509,000 | ||||||||||||||
Cash at beginning of year | 1,846,700 | 1,362,800 | 5,337,800 | 1,846,700 | ||||||||||||
Cash at end of period | $ | 5,355,700 | $ | 2,136,600 | $ | 10,476,500 | $ | 5,355,700 | ||||||||
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||||||||||||||||
Accumulated depreciation and amortization | $ | — | $ | 600 | ||||||||||||
Furniture, fixtures and equipment | $ | — | $ | (600 | ) |
*See accompanying notes to these financial statements.
3 |
Nocopi Technologies, Inc.
Statements of Stockholders’ Equity*
For the Periods December 31, 2022 through September 30, 2023 and December 31, 2021 through September 30, 2022 and December 31, 2020 through September 30, 2021
(unaudited)
Common stock | Paid-in | Accumulated | ||||||||||||||||||
Shares ** | Amount ** | Capital ** | Deficit | Total | ||||||||||||||||
Balance as of December 31, 2021 | 6,751,178 | $ | 67,500 | $ | 13,184,600 | $ | (9,746,800 | ) | $ | 3,505,300 | ||||||||||
Net loss | — | — | — | (203,400 | ) | (203,400 | ) | |||||||||||||
Balance as of March 31, 2022 | 6,751,178 | 67,500 | 13,184,600 | (9,950,200 | ) | 3,301,900 | ||||||||||||||
Net loss | — | — | — | (297,000 | ) | (297,500 | ) | |||||||||||||
Balance as of June 30, 2022 | 6,751,178 | $ | 67,500 | $ | 13,184,600 | $ | (10,247,200 | ) | $ | 3,004,900 | ||||||||||
Sales of common stock | 2,500,000 | 25,000 | 3,475,000 | — | 3,500,000 | |||||||||||||||
Net income | — | — | — | 206,500 | 206,500 | |||||||||||||||
Balance as of September 30, 2022 | 9,251,178 | $ | 92,500 | $ | 16,659,600 | $ | (10,040,700 | ) | $ | 6,711,400 |
Common stock | Paid-in | Accumulated | ||||||||||||||||||
Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
Balance as of December 31, 2022 | 9,251,178 | $ | 92,500 | $ | 16,659,600 | $ | (7,933,700 | ) | $ | 8,818,400 | ||||||||||
Net income | — | — | — | 30,300 | 30,300 | |||||||||||||||
Balance as of March 31, 2023 | 9,251,178 | $ | 92,500 | $ | 16,659,600 | $ | (7,903,400 | ) | $ | 8,848,700 | ||||||||||
Net income | — | — | — | 79,100 | 79,100 | |||||||||||||||
Balance as of June 30, 2023 | 9,251,178 | $ | 92,500 | $ | 16,659,600 | $ | (7,824,300 | ) | $ | 8,927,800 | ||||||||||
Sales of common stock | 1,250,000 | 12,500 | 4,987,500 | — | 5,000,000 | |||||||||||||||
Net income (loss) | — | — | — | (453,300 | ) | (453,300 | ) | |||||||||||||
Balance as of September 30, 2023 | 10,501,178 | $ | 105,000 | $ | 21,647,100 | $ | (8,277,600 | ) | $ | 13,474,500 |
Common stock | Paid-in | Accumulated | ||||||||||||||||||
Shares ** | Amount ** | Capital ** | Deficit | Total | ||||||||||||||||
Balance as of December 31, 2020 | 6,737,041 | $ | 67,400 | $ | 13,181,900 | $ | (9,796,200 | ) | $ | 3,453,100 | ||||||||||
Net income | — | — | — | 114,800 | 114,800 | |||||||||||||||
Balance as of March 31, 2021 | 6,737,041 | 67,400 | 13,181,900 | (9,681,400 | ) | 3,567,900 | ||||||||||||||
Exercise of warrants | 14,137 | 100 | 2,700 | — | 2,800 | |||||||||||||||
Net income | — | — | — | 42,500 | 42,500 | |||||||||||||||
Balance as of June 30, 2021 | 6,751,178 | $ | 67,500 | $ | 13,184,600 | $ | (9,638,900 | ) | $ | 3,613,200 | ||||||||||
Net income | — | — | — | 1,100 | 1,100 | |||||||||||||||
Balance as of September 30, 2021 | 6,751,178 | $ | 67,500 | $ | 13,184,600 | $ | (9,637,800 | ) | $ | 3,614,300 |
Common stock | Paid-in | Accumulated | ||||||||||||||||||
Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
Balance – December 31, 2021 | 6,751,178 | $ | 67,500 | $ | 13,184,600 | $ | (9,746,800 | ) | $ | 3,505,300 | ||||||||||
Net loss | — | — | — | (203,400 | ) | (203,400 | ) | |||||||||||||
Balance – March 31, 2022 | 6,751,178 | 67,500 | 13,184,600 | (9,950,200 | ) | 3,301,900 | ||||||||||||||
Net loss | — | — | — | (297,000 | ) | (297,000 | ) | |||||||||||||
Balance June 30, 2022 | 6,751,178 | $ | 67,500 | $ | 13,184,600 | $ | (10,247,200 | ) | $ | 3,004,900 | ||||||||||
Sales of common stock | 2,500,000 | 25,000 | 3,475,000 | — | 3,500,000 | |||||||||||||||
Net income | — | — | — | 206,500 | 206,500 | |||||||||||||||
Balance as of September 30, 2022 | 9,251,178 | $ | 92,500 | 16,659,600 | $ | (10,040,700 | ) | $ | 6,711,400 |
* See accompanying notes to these financial statements.
4 |
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
(UNAUDITED)
Note 1.Financial Statements
The accompanying unaudited condensed financial statements have been prepared by Nocopi Technologies, Inc. (our “Company”). These statements include all adjustments (consisting only of normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting policies described in Note 2 Significant Accounting Policies included in the Notes to Financial Statements included in our Company’s Annual Report on Form 10-K for the year ended December 31, 2021,2022, as filed with the Securities and Exchange Commission on March 30, 2022,31, 2023, as amended on April 29, 202228, 2023 (the “2021“2022 Annual Report”). Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although our Company believes that the accompanying disclosures are adequate to make the information presented not misleading. The Notes to Financial Statements included in the 20212022 Annual Report should be read in conjunction with the accompanying interim financial statements. The interim operating results for the three months and nine months ended September 30, 20222023 may not be necessarily indicative of the operating results expected for the full year.
A novel strain of coronavirus, COVID-19, that was first identified in Wuhan, China in December 2019 has surfaced in many countries around the world including the United States. Many countries continue to experience reoccurrences of COVID-19 to the current date. The World Health Organization has declared COVID-19 to constitute a global pandemic. Certain state and local governments reacted by placing significant restrictions on businesses including a closure in Pennsylvania of non-essential businesses that was announced on March 20, 2020. While most Pennsylvania businesses have been allowed to reopen, often at limited capacity and with certain restrictions, as of the current date, there can be no assurances that future closures will be avoided. A requirement to close our Company for a considerable period of time could result in a negative impact on our Company’s financial condition and results of operations. Additionally, as our Company imports certain raw materials from China, if an extended disruption of the supply of these raw materials were to occur, such as the vessel delays resulting from the congestion experienced in certain Chinese ports due to a COVID-19 outbreak in the second quarter of 2021 and continuing to the present time, our ability to produce products for sale to our customers could be negatively impacted. Additionally, certain of the Company’s licensees in the entertainment and toy products market who utilize printers in China to produce their products have been affected by the COVID-19 related cargo surge beginning in the third quarter of 2021 and continuing to the present time at major Chinese and United States ports as well as the world-wide container shortage resulting in significantly higher shipping costs, and have responded by deferring or scaling back production of their orders and, in some cases, rescheduling the shipping of completed orders. Such deferrals may affect the number and value of orders placed by the Company’s licensed printers in the entertainment and toy products market. Further, restrictions on our customers and licensees in areas affected by the COVID-19 could adversely affect our results of operations and financial condition. Our Company’s operating results for the first nine months of 2022 are reflective of the effects of the ongoing cargo surge as well as lockdowns in certain Chinese cities that are continuing to the present time, including the two month lockdown in Shanghai during the first half of 2022 that continues to affect businesses and production in those areas. As the COVID-19 pandemic continues to spread with the Omicron variants including BA.5, currently the most dominant variant, as well as other recently identified variants and sub-variants including BA4.6, BQ.1 and BQ.1.1, any future financial impact cannot be reasonably estimated at this time. We cannot predict the scope or magnitude of the negative effect that may result from the impact of the COVID-19 pandemic on the Company’s financial condition and results of operations. Our Company’s results of operations were negatively affected in earlier periods in part as a result of a significant increase in the cost of raw materials utilized by our Company in the manufacture of certain of its products as a result of price increases related to the impact of the ongoing COVID-19 pandemic on the availability and supply of these raw materials. While prices of these raw materials have declined at the present time, there can be no assurances that raw material prices will remain at current levels or decrease to pre-COVID-19 pandemic levels in future periods. As the COVID-19 pandemic continues to spread both in its original form and in the recently identified variants of COVID-19 along with the potential re-imposition of COVID-19 restrictions that may be considered by federal, state and local governments, any future financial impact cannot be reasonably estimated at this time.
Our Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 220 in reporting comprehensive income (loss). Comprehensive income (loss) is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.income (loss). Since our Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).
5
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
(UNAUDITED)
Note 2. Revenues
Our Company follows ASU 214-09, Revenue from Contracts with Customers (“Topic 606”), using the modified retrospective method. The adoption of the guidance affected our recognition of revenue from licenses and royalties. Since its adoption in 2018, we recognize revenue from licensees and royalties at a point in time when the term begins. During the third quarter of 2022, we negotiated an amendment to a license agreement with a licensee that provides for a five year extension to the license agreement that contains guaranteed royalties payable in installments over the term of the amendment to the license agreement. Since the performance obligation is to grant the license for the use of certain patented ink technology as it exists at the time that it is granted, the promise to grant the license is a performance obligation satisfied at a point in time in accordance with Topic 606. In accordance with Topic 606, we recorded $241,000 net of imputed interest of licenses, royalties and fees and $16,900 of selling expenses in the third quarter and first nine months of 2022 related to the amendment to the license agreement. The related receivable and payable are recorded as other assets and other liabilities on the balance sheet.
Note 3. 2.Stock Based Compensation
Our Company follows FASB ASC 718, Compensation – Stock Compensation, and uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. At September 30, 2022,2023, our Company did not have an active stock option plan. There was unrecognized portion of expense related to stock option grants at September 30, 2022.2023.
As part of an employment agreement, the Company granted an executive a one-time equity award of 3,580,000, fair value, which award shall vest in its entirety on August 18, 2024. The fair market value of the restricted stock award was determined based on the closing price of the Company’s common stock on the grant date and is being amortized on a straight-line basis to general and administrative expense as stock based compensation over the one year vesting term. The Company recorded stock based compensation expense of $ for the three and nine months ended September 30, 2023. To the extent the Company has not established an employee equity compensation plan on or prior to August 18, 2024, the restricted shares may be converted, at the election of the executive, in full or in part, into cash compensation, at a rate of $ per share of common stock, which was the fair market value of the common stock on August 18, 2023, which was the commencement date of the employment agreement. Since the issuance of the restricted stock can be settled in cash, the monthly amortization of the $3,580,000 fair value of the restricted stock grant is recorded as stock compensation payable. If the restricted stock grant is settled in shares of the Company’s common stock, then the stock compensation payable will be reclassified to additional paid in capital.
restricted shares of the Company’s common stock valued at $5 |
NOCOPI TECHNOLOGIES, INC. NOTES TO FINANCIAL STATEMENTS (UNAUDITED) |
Note 3. Cash and Cash Equivalents
Schedule of Cash and Cash Equivalents | ||||||||
September 30 2023 | December 31 2022 | |||||||
Cash and cash equivalents | ||||||||
Cash and money market funds | $ | 1,315,700 | $ | 917,400 | ||||
U.S. Treasury Bills | 9,160,800 | 4,420,400 | ||||||
Cash and cash equivalents | $ | 10,476,500 | $ | 5,337,800 |
The amortized cost and fair value of securities held to maturity at September 30, 2023 are as follows:
Schedule of amortized cost and fair value of securities held to maturity | ||||||||
Amortized Cost | Fair Value | |||||||
U.S. Treasury Bills | ||||||||
Due October 5, 2023 | 1,124,200 | 1,124,500 | ||||||
Due January 25, 2024 | 1,108,700 | 1,105,900 | ||||||
Due April 18, 2024 | 1,092,600 | 1,092,300 | ||||||
Due July 11, 2024 | 1,079,400 | 1,078,900 | ||||||
Due September 5, 2024 | 4,756,000 | 4,755,800 | ||||||
Total | $ | 9,160,900 | $ | 9,157,400 |
Note 4. Line of CreditLong-term Receivables
In November 2018, ourAs of September 30, 2023, the Company negotiatedhad long-term receivables of $1,993,700 from three licensees representing the present value of fixed guaranteed royalty payments that will be payable over varying periods of two through five years that commenced in the second half of 2022 and terminate in the second quarter of 2028. The fixed guaranteed royalty payments result from amendments to license agreements with two existing licensees and a $150,000 revolving line of creditlicense agreement with a bank to provide a sourcenew licensee. The receivable represents the present value of working capital, if required. The line of credit is secured by all the assets of our Company and bears interestfixed minimum annual payments due under the license agreements, discounted at the bank’s primeCompany's incremental borrowing rate of 4%.
The three agreements grant licenses for the use of certain patented ink technology as it exists at the time that it is granted which is considered functional intellectual property. Under Topic 606, a periodperformance obligation to transfer a license for functional intellectual property is satisfied at a point in time and the fixed consideration could be recognized upfront when the Company transfers control of onethe licensee if certain criteria are met. Specifically, the minimum royalty guarantee could be recognized upfront if the following conditions are met:
· | The royalty payment is fixed or determinable |
· | Collection of the royalty payment is considered probable |
· | The licensee has the ability to benefit from the licensed technology |
The Company determined that the above conditions were met upon execution of the agreements and, in the year ended December 31, 2022, recognized $2,810,600 of royalty revenue along with $206,600 of commission expense net of imputed interest of $131,300. The commissions are payable over the term of the license agreements and its prime rate plus 1.5% thereafter.are due when payments are received by the Company. As of September 30, 2023, the accrued commission payable balance was approximately $183,000.
The current portion of the three new license agreements, in the amount of $624,100 is included in accounts receivable on the balance sheet as of September 30, 2023. The linecurrent portion of creditthe license agreement entered into in prior years, in the amount of $507,500, is subject to an annual review and quiet period. There have been no borrowingsincluded in accounts receivable on the balance sheet as of December 31, 2022
6 |
NOCOPI TECHNOLOGIES, INC. NOTES TO FINANCIAL STATEMENTS (UNAUDITED) |
The following table summarizes the future minimum payments due under the linethree new license agreements as of credit sinceSeptember 30, 2023:
Schedule of future minimum payments | ||||||
Year Ending December 31: | ||||||
2023 | $ | 157,500 | ||||
2024 | 642,000 | |||||
2025 | 570,000 | |||||
2026 | 570,000 | |||||
2027 | 557,500 | |||||
2028 | 260,000 | |||||
Total | $ | 2,757,000 |
The Company has evaluated the collectibility of the long-term receivables and believes them to be fully collectible as of September 30, 2023. However, there can be no assurance that the receivables will not be impaired in the future due to changes in the licensees’ financial condition or other factors.
The long-term receivables are recorded at its inception.present value as of September 30, 2023, and will be amortized over the term of the license agreements using the effective interest method. The unamortized balance of the long-term receivables as of September 30, 2023 is $1,993,700.
Note 5. Stockholders’ Equity
On August 25, 2022 our Company filed Articles of Amendment to its Articles of Incorporation with the State Department of Assessments and Taxation of the State of Maryland to effect a one-for-ten (1:10) reverse stock split of our Company’s common stock, par value $0.01 per share (the “Reverse Stock Split”). The August 25, 2022 Articles of Amendment become effective as of 12:01 a.m. Eastern Standard Time on September 2, 2022 (the “Effective Time”). At the Effective Time, every ten shares of common stock of our Company that were issued and outstanding immediately prior to the Effective Time were changed into one issued and outstanding share of common stock of our Company. The Reverse Stock Split did not affect any stockholder’s ownership percentage of our Company’s shares, except to the limited extent that the Reverse Stock Split resulted in any stockholder owning a fractional share. No fractional shares were issued in connection with the Reverse Stock Split. Each stockholder who would otherwise have been entitled to receive a fraction of a share of our Company’s common stock instead received one whole share of common stock. There was no change to the number of authorized shares or the par value per share. Unless we indicate otherwise, all information in this Quarterly Report on Form 10-Q gives pro forma effect to the Reverse Stock Split and the corresponding adjustment of all common stock price per share and common stock warrant price data.
On August 1, 202211, 2023 our Company entered into a stock purchase agreement (the “Purchase Agreement”) in connection with a private placement for total gross proceeds of $3.5 5.0million. The stock purchase agreementPurchase Agreement provided for the issuance of an aggregate of shares of our Company’s common stock to two investorsan investor at a purchase price of $ per share. To enableIn addition, as consideration for general advisory services until the private placement transaction, our Company’sthird anniversary, the Company agreed to issue an aggregate total of shares of Directors approved common stock with a total fair market value on date of grant of $65,790, which Advisory Shares shall be issued as follows: one-third (21,930 Advisory Shares) on September 11, 2024, one-third (21,930 Advisory Shares) on September 11, 2025 and one-third on September 11, 2026. The Company expenses the Reverse Stock Split.value of the stock grant, which is determined to be the fair market value of the shares at the date of grant, straight-line over the term of the advisory agreement. On September 13, 2022,11, 2023, the sale pursuant to thestock purchase agreement Purchase Agreement closed. No placement fees or commissions were paid in connection with this transaction.
During the second quarter of 2021, holders of the remaining warrants that had been outstanding exercised their options to purchase a total of 14,137 shares of our Company’s common stock at $0.20 per share. The warrants were granted in 2014 to two individuals who acquired convertible debentures from the Company in 2014. The warrants were exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since our Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances was accreted through interest expense over the term of the notes payable. At September 30, 2022, our Company had no warrants outstanding.
6
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
(UNAUDITED)
Note 6. Income Taxes
There iswas no provisionincome tax benefit for federal income taxesthe net losses for the three months ended September 30, 2022 due to the availability of net operating loss carryforwards. There is no income tax benefit for the losses for2023 and the nine months ended September 30, 2023 and 2022 because our Company has determined that the realization of the next deferred tax asset is not assured. There is no provision for federal income taxes for the three and nine months ended September 30, 2021 due to the availability of net operating loss carryforwards. Our Company has established a valuation allowance for the entire amount of benefits resulting from our Company’s net operating loss carryforwards because our Company has determined that the realization of the net deferred tax asset iswas not assured. Our Company created a valuation allowance for the entire amount of such benefits. However, the income tax benefit reflected on the Statement of Comprehensive Income (Loss) for the three and nine months ended September 30, 2023 is the result of reversing the tax accruals. There is no provision for income taxes for the three months ended September 30, 2023 due to the availability of net operating loss carryforwards.
The components for federal and state income tax expense resulting from the limitation on the use of net operating losses are:
Components for State Income Tax Expense | ||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||
September 30 | September 30 | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Current state taxes | $ | — | $ | (10,200 | ) | $ | — | $ | 1,700 | |||||||
Deferred state taxes | — | — | — | — | ||||||||||||
$ | — | $ | (10,200 | ) | $ | — | $ | 1,700 |
Schedule of federal and state income tax expense | ||||||||||||||||
Three Months ended September 30 | Nine Months ended September 30 | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Current federal taxes | $ | (154,500 | ) | $ | — | $ | (122,700 | ) | $ | — | ||||||
Current state taxes | (6,100 | ) | — | — | — | |||||||||||
Total | $ | (160,600 | ) | $ | — | $ | (122,700 | ) | $ | — |
There was no change in unrecognized tax benefits during the period ended September 30, 20222023 and there was no accrual for uncertain tax positions as of September 30, 2022.
2023. Tax years from 20192020 through 20212022 remain subject to examination by U.S. federal and state jurisdictions. There is no Federal net operating loss carryforward and $1,657,892 of Pennsylvania State net operating loss carryforward as of September 30, 2023.
7 |
NOCOPI TECHNOLOGIES, INC. NOTES TO FINANCIAL STATEMENTS (UNAUDITED) |
In accordance with FASB ASC 260, Earnings per Share, basic earnings (loss) per common share is computed using net earnings (loss) divided by the weighted average number of common shares outstanding for the periods presented. Diluted earnings (loss) per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Since our Company did not have any common stock equivalents outstanding as of September 30, 20222023 and 2021,September 30, 2022, basic and diluted earnings (loss) per share were the same.
Note 8. Major Customer and Geographic Information
Our Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of ourthe Company’s total revenues were:
Company's Revenues As Percentage Of Revenue | ||||||||||||||||||||||||||||||||
Company's revenues as percentage of revenue | ||||||||||||||||||||||||||||||||
Three Months ended September 30 | Nine Months ended September 30 | Three Months ended September 30 | Nine Months ended September 30 | |||||||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||
Customer A | 32 | % | 24 | % | 45 | % | 47 | % | 69 | % | 32 | % | 69 | % | 45 | % | ||||||||||||||||
Customer B | 20 | % | 43 | % | 22 | % | 24 | % | 18 | % | 20 | % | 17 | % | 22 | % | ||||||||||||||||
Customer C | — | — | — | 11 | % | |||||||||||||||||||||||||||
Customer D | 40 | % | — | 20 | % | — | — | 40 | % | — | 20 | % |
Our Company’s non-affiliate customers whose individual balances amounted to more than 10% of our Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:
Schedule of Non-affiliated Customers with Accounts Receivable More Than 10% | ||||||||||||||||
Schedule of non-affiliated customers with accounts receivable more than 10% | ||||||||||||||||
September 30 | December 31 | September 30 | December 31 | |||||||||||||
2022 | 2021 | 2023 | 2022 | |||||||||||||
Customer A | 25 | % | 30 | % | 16 | % | 6 | % | ||||||||
Customer B | 43 | % | 65 | % | 73 | % | 84 | % | ||||||||
Customer D | 28 | % | 2 | % |
Our Company performs ongoing credit evaluations of its customers and generally does not require collateral. Our Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on our Company’s business operations and financial condition.
7
NOCOPI TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
(UNAUDITED)
Our Company’s revenues by geographic region are as follows:
Company's revenue by geographic region | ||||||||||||||||
Three Months ended September 30 | Nine Months ended September 30 | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
North America | $ | 140,700 | $ | 184,200 | $ | 414,300 | $ | 469,000 | ||||||||
South America | 600 | — | 600 | 1,600 | ||||||||||||
Europe | — | 200 | — | 200 | ||||||||||||
Asia | 409,900 | 229,300 | 1,286,600 | 757,200 | ||||||||||||
Australia | 23,900 | 272,200 | 64,900 | 311,600 | ||||||||||||
$ | 575,100 | $ | 685,900 | $ | 1,766,400 | $ | 1,539,600 |
Company's Revenue by Geographic Region | ||||||||||||||||
Three Months ended September 30 | Nine Months ended September 30 | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
North America | $ | 184,200 | $ | 204,200 | $ | 469,000 | $ | 515,100 | ||||||||
South America | — | — | 1,600 | 4,100 | ||||||||||||
Europe | 200 | — | 200 | — | ||||||||||||
Asia | 229,300 | 77,500 | 757,200 | 853,100 | ||||||||||||
Australia | 272,200 | 30,800 | 311,600 | 65,500 | ||||||||||||
$ | 685,900 | $ | 312,500 | $ | 1,539,600 | $ | 1,437,800 |
8 |
NOCOPI TECHNOLOGIES, INC. NOTES TO FINANCIAL STATEMENTS (UNAUDITED) |
Note 9. Leases
Our Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2024.
Due to the adoption of the new lease standard under the optional transition method which allows the entity to apply the new lease standard at the adoption date, our Company has capitalized the present value of the minimum lease payments commencing January 1, 2019, using an estimated incremental borrowing rate of 6.5%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.
As of January 1, 2019 the operating lease right-of-use asset and operating lease liability amounted to $241,100 with no cumulative-effect adjustment to the opening balance of accumulated deficit.
There are no other material operating leases. Our Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.
Total lease expense under operating leases for the three and nine months ended September 30, 20222023 was $13,300 and $40,000, respectively. Total lease expense under operating leases for the three and nine months ended September 30, 20212022 was $13,300 and $40,000, respectively.
Maturities of lease liabilities are as follows:
Schedule of maturities of lease liabilities | ||||
Operating Leases | ||||
Year ending December 31 | ||||
2023 | 14,200 | |||
2024 | 18,900 | |||
Total lease payments | 33,100 | |||
Less imputed interest | (2,500 | ) | ||
Total | $ | 30,600 |
Maturities of Lease Liabilities | ||||
Operating Leases | ||||
Year ending December 31 | ||||
2022 | $ | 13,700 | ||
2023 | 56,200 | |||
2024 | 18,900 | |||
Total lease payments | 88,800 | |||
Less imputed interest | (8,400 | ) | ||
Total | $ | 80,400 |
Note 10. Employee Retention Tax Credit
The CARES Act, signed into law on March 27, 2020 with subsequent amendments, provides for refundable employee retention credit to employers whose operations were suspended due to COVID-19 or whose revenue significantly decreased. On June 15, 2023, the Company filed a Form 941-X to claim a refundable employee retention credit for the first quarter and third quarter 2021 payroll in the total amount of $84,000. The Company will record the credit as other income in the Statement of Comprehensive Income in the period the refund is received.
9 |
NOCOPI TECHNOLOGIES, INC. NOTES TO FINANCIAL STATEMENTS (UNAUDITED) |
Note 11. Subsequent Events
In connection with Michael S. Liebowitz’s appointment as Chief Executive Officer of the Company, on October 19, 2023, Mr. Liebowitz and the Company entered into an employment agreement (the “Employment Agreement”), which sets forth the terms and conditions of his employment and is effective as of October 19, 2023.
Pursuant to the Employment Agreement, Mr. Liebowitz serves as our Chief Executive Officer for an initial term of five years, commencing on August 18, 2023, the date of his appointment (the “Term Commencement Date”), and for successive periods of one year after the expiration of the initial term, unless either party gives the other party written notice of termination at least 180 days prior to the termination date of the applicable term period, or unless the Employment Agreement is otherwise terminated in accordance with its term. In consideration for serving as Chief Executive Officer, Mr. Liebowitz is entitled to an annual base salary of $400,000, which is effective retroactively as of the Term Commencement Date. In addition, Mr. Liebowitz shall be entitled to a one-time equity award of restricted shares (the “Equity Award”) of the Company’s common stock valued at $3,580,000, fair value, which award shall vest in its entirety on August 18, 2024. The fair market value of the restricted stock award was determined based on the closing price of the Company’s common stock on the grant date and is being amortized to expense over the vesting term. The Company recorded total expense of $420,600 for the three and nine months ended September 30, 2023. To the extent the Company has not established an employee equity compensation plan on or prior to August 18, 2024, the Equity Award may be converted, at the election of Mr. Liebowitz, in full or in part, into cash compensation, at a rate of $ per share of common stock, the fair market value of the common stock as of the Term Commencement Date. Mr. Liebowitz is also entitled to participate in all insurance and other fringe benefit programs of the Company to the extent and on the same terms and conditions as are accorded to other management employees of the Company.
In the event (i) Mr. Liebowitz resigns “For Good Reason” or (ii) the Company terminates his employment for any reason other than “For Good Cause”, excluding instances of Mr. Liebowitz’s death or “Total Disability”, (each as defined in the Employment Agreement), he is entitled to receive the following payments and benefits, in addition to any accrued obligations and subject to his timely execution and non-revocation of a general release of claims in the Company’s favor and continued compliance with the restrictive covenants contained in the Employment Agreement: (i) an amount equal to twelve (12) months of his then base salary, which sum shall be payable on a bi-weekly basis from and after the date of any such termination and (ii) any unvested shares of common stock deriving from the Equity Award shall immediately vest and, upon August 18, 2024, shall be issued.
In the event of Mr. Liebowitz’s termination due to his death or Total Disability, 50% of any unvested shares of common stock under the Equity Award shall immediately vest and, upon August 18, 2024, shall be issued to Mr. Liebowitz’s designated beneficiary or, if none, to his estate, in addition to any accrued obligations.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.Operations
Forward-Looking Information
This reportReport on Form 10-Q contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding:
· | Expected operating results, such as revenue, | |
· | Current or future volatility in market conditions | |
· | Our belief that we have sufficient liquidity to fund our business operations during the next twelve months | |
· | Strategy for customer retention, growth, product development, market position, | |
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:
· | The extent to which | |
· | Strategic actions, including business acquisitions and our success in integrating acquired businesses. | |
· | Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so. | |
· | The impact of losing our intellectual property protections or the loss in value of our intellectual property. | |
· | Changes in customer demand. | |
· | The | |
· | Developments and changes in | |
· | Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems. | |
· | Such other factors as discussed throughout Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q, and throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and in Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, |
11 |
Any forward-looking statement made by us in this reportReport on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.otherwise.
The following discussion and analysis should be read in conjunction with our condensed financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management. This information should also be read in conjunction with our audited historical financial statements which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021,2022, filed with the Securities and Exchange Commission on March 30, 2022,31, 2023, as amended on April 29, 2022.28, 2023.
Background Overview
Nocopi Technologies, Inc. develops and markets specialty reactive inks for applications in the large educational and toy products market. We also develop and market technologies for document and product authentication, which we believe can reduce losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.
Unless the context otherwise requires, all references to the ““CompanCompanyy,” “we,“we,” “our”“our” or “us”“us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation.
Effects of COVID-19
To serve our customers while also providing for the safety of our employees and service providers, we have adapted various steps to protect our employees. Any employee who is uncomfortable coming into our facilities may choose not to come in. We have a large enough facility to enable all of our employees to social distance and we follow Centers for Disease Control and Prevention (CDC) guidelines. Our production employees work with chemicals and they have always used masks, respirators, etc., even before COVID-19. As a result, we continue to maintain the same level of productivity and effectiveness as prior to the COVID-19 pandemic.
The impact of COVID-19 on our Company had little effect on the financial results during the first six months of 2021 as the shortage of raw materials used in certain of our Company’s products experienced throughout 2020 as a consequence of the COVID-19 pandemic and the resultant price increases were at least temporarily eased, though still higher than pre-pandemic levels, so our Company’s gross margins on those products returned to similar levels as were experienced before the inception of the COVID-19 pandemic; however, in the third quarter of 2021, certain of the Company’s licensees in the entertainment and toy products market who utilize printers in China to produce their products have been adversely affected by the cargo surge related to congestion experienced in certain Chinese ports due to a COVID-19 outbreak that began in the second quarter of 2021. The cargo surge continues to the present time, now adversely affecting major United States ports. The world-wide cargo surge along with a container shortage resulted in significantly higher shipping costs during the third quarter of 2021. Certain of our Company’s licensees in the entertainment and toy products market have responded by deferring or scaling back production and size of future orders, and, in some cases, rescheduling the shipping of completed orders. Ink orders from our Company’s licensed printers in China fell significantly in the third quarter of 2021 compared to earlier periods. These supply chain disruptions are being experienced by many businesses including our Company’s licensees. A continuance of these supply chain disruptions may negatively impact the number and value of orders placed by our Company’s licensed printers in the entertainment and toy products market with a resultant negative impact on our Company’s results of operations and cash flow in future periods.
To date, we have not suffered a drop off in total earned royalties in the entertainment and toy products market as a result of COVID-19 as retail demand continues to be strong for the products marketed by our licensees in the entertainment and toy products market; however, during the third quarter of 2021, reflecting the significantly higher shipping costs caused by the COVID-19 related cargo surge at major China and United States ports and the world-wide container shortage, ink orders from the printers of our licensees in the entertainment and toy products market were significantly below historical levels. We continue to experience a negative impact on revenues in our smaller anti-counterfeiting and anti-diversion products market due to reduced production activity at certain printing facilities that utilize these technologies and anticipate that these conditions may continue for a period of time. We continue to retain licensing revenues at historical levels in the entertainment and toy products market through the current date despite the downturns in the overall economy. While the products of our licensees in the larger entertainment and toy products market are sold by both large and smaller retailers, some of whom remain open, and are also available for purchase online, we believe that revenues may not continue to be achieved at levels experienced to the current date due to the negative economic conditions that are expected to continue over the balance of the year and beyond as a result of COVID-19. A slowdown in overall consumer spending may affect the sales of products marketed by our licensees. Our major licensees in the entertainment and toy products market are large, well-known businesses in this market with whom we believe our long-term relationship will not be adversely affected by the current COVID-19 pandemic.
Results of Operations
Our Company’s revenues are derived from (a) royalties paid by licensees of our technologies, (b) fees for the provision of technical services to licensees and (c) from the direct sale of (i) products incorporating our technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of our technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by our licensees in certain cases and additional royalties which typically vary with the licensee’s sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.
Our Company recognizes revenue on its lines of business as follows:
a. | License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins; | |
b. | Product sales are recognized at the time of the transfer of goods to customers at an amount that our Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and | |
c. | Fees for technical services are recognized at the time of the transfer of services to customers at an amount that our Company expects to be entitled to in exchange for the services, which is when the service has been rendered. |
We believe that, as fixed cost reductions beyond those we have achieved in recent years may not be achievable, our operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.
Both the absolute amount of our Company’s revenues and the mix among the various sources of revenue are subject to substantial fluctuation. We have a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on our Company’s total revenue, revenue mix and overall financial performance. Such changes may result from a substantial customer’s product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when our Company agrees to revise such terms, revenues from the customer may be adversely affected.
12 |
Revenues for the third quarter of 20222023 were $685,900$575,100 compared to $312,500 in the third quarter of 2021, an increase of $373,400, or approximately 119%. Revenues$685,900 in the third quarter of 2022, included, in accordance with ASU 214-09, Revenue from Contracts with Customers (“Topic 606”), revenuea decrease of $241,000 representing the present value of guaranteed royalty payments that will be payable over a five-year period beginning in the fourth quarter of 2022 as a result of an amendment to a license agreement with a licensee that provides for a five year extension to the license agreement beginning in October 2022. Since the performance obligation is to grant the license for the use of certain patented ink technology as it exists at the time that it is granted, the promise to grant the license is a performance obligation satisfied at a point in time in accordance with Topic 606. Prior to 2018, we recognized revenue from licenses and royalties on a straight-line basis over the term of the related license agreement.$110,800, or approximately 16%. Licenses, royalties and fees increaseddecreased by $226,100,$310,600, or approximately 102%69%, to $136,900 in the third quarter of 2023 from $448,600 in the third quarter of 2022 from $222,500 in the third quarter of 2021.2022. The increasedecrease in licenses, royalties and fees in the third quarter of 20222023 compared to the third quarter of 20212022 is due primarily to higherlower royalties from our Company’s licensees in the entertainment and toy products market due to ongoing strong retail demand for these products offset in part by lower revenues from our licensees in the security markets. We cannot assure you that the marketing and product development activities of our Company’s licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for our Company, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions being experienced worldwide as a result of the COVID-19 pandemic that is continuing to negatively impact all worldwide economies along with the massive international supply chain disruptions currentlypresently being experienced. The products marketed by the Company’s major licensees in the entertainment and toy products markets are produced in China. Trans-Pacific ocean shipping has been negatively affected by container shortages and port delays both in the United States and China.
Product and other sales increased by $147,300,$200,900, or approximately 164%85%, to $438,200 in the third quarter of 2023 from $237,300 in the third quarter of 2022 from $90,000 in the third quarter of 2021.2022. Sales of ink increased in the third quarter of 20222023 compared to the third quarter of 20212022 due primarily to higher ink shipments to the third party authorized printer used by onetwo of our Company’s major licensees in the entertainment and toy products market. In the third quarter of 2022,2023, our Company derived revenues of approximately $648,300$566,100 from our licensees and their authorized printers in the entertainment and toy products market compared to revenues of approximately $257,000$648,300 in the third quarter of 2021.2022.
For the first nine months of 2022,2023, revenues were $1,539,600,$1,766,400, representing an increase of $101,800,$226,800, or approximately 7%15%, from revenues of $1,437,800$1,539,600 in the first nine months of 2021.2022. Licenses, royalties and fees increaseddecreased by $202,800,$345,600, or approximately 37%46%, to $410,100 in the first nine months of 2023 from $755,700 in the first nine months of 2022 from $552,900 in the first nine months of 2021.2022. The increasedecrease in licenses, royalties and fees is due primarily to higher royalties from our Company’s licensees in entertainment and toy products market including $241,000 representing the present valuerenewal of guaranteed royalty payments that will be payable over a five-year period beginning in the fourth quarter of 2022 as a result of an amendment to a license agreement with a licensee that provides for a five year extension to the license agreement beginning in October 2022 described above offset in part by lower revenues from certainone of our Company’s licensees in September 2022 in the security markets which continue to be negatively affected by the COVID-19 pandemicentertainment and the variants of COVID-19 that have recently been identified.toy products market. We cannot assure you that the marketing and product development activities of our Company’s licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for our Company, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions presently being experienced worldwide as a result of the COVID-19 pandemic that is continuing to negatively impact all worldwide economies along with recently identified variants of the COVID-19 virus.experienced.
Product and other sales decreasedincreased by $101,000,$572,400, or approximately 11%73%, to $1,356,300 in the first nine months of 2023 from $783,900 in the first nine months of 2022 from $884,9002022. Sales of ink increased in the first nine months of 2021. Sales of ink decreased in the first nine months of 20222023 compared to the first nine months of 20212022 due primarily to lowerhigher ink shipments to the third party authorized printer used by onetwo of our Company’s major licensees in the entertainment and toy products market along with lower ink shipments to our Company’s licensees in the retail receipt and document fraud market. Our Company derived revenues of approximately $1,426,100$1,687,700 from licensees and their authorized printers in the entertainment and toy products market in the first nine months of 20222023 compared to revenues of approximately $1,279,700$1,426,100 in the first nine months of 2021.2022.
Our Company’s gross profit increaseddecreased to $265,100 in the third quarter of 2023, or approximately 46% of revenues, from $493,500 in the third quarter of 2022, or approximately 72% of revenues, from $209,200 in the third quarter of 2021 or approximately 67% of revenues. Licenses, royalties and fees have historically carried a higher gross profit than product and other sales. Such other sales, which generally consist of supplies or other manufactured products which incorporate our Company’s technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by our Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees. The higher gross profit in the third quarter of 2022 compared to the third quarter of 2021 results primarily from higher gross revenues from licenses, royalties and fees and product and other sales.
For the first nine months of 2022,2023, gross profit was $946,900, or approximately 54% of revenues, compared to $979,800, or approximately 64% of revenues, compared to $880,400, or approximately 61%in the first nine months of revenues in 2021.2022. The lower gross profit in the first nine months of 20222023 compared to the first nine months of 2021 results2022 was primarily from lower revenuesdue to a decrease in gross profit from product and other sales offset in part by higher revenues from licenses, royalties and fees in the first nine months of 2022 compared to the first nine months of 2021.sales.
As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both the gross profit from licenses, royalties and fees as well as overall gross profit. The gross profit from licenses, royalties and fees increaseddecreased to approximately 54% in the third quarter of 2023 compared to approximately 90% in the third quarter of 2022 compared to approximately 87% in the third quarter of 2021 and to approximately 83%58% of revenues from licenses, royalties and fees in the first nine months of 20222023 from approximately 77%83% in the first nine months of 2021.2022.
13 |
The gross profit, expressed as a percentage of revenues, of product and other sales is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. The gross profit from product and other sales increased to approximately 44% of revenues in the third quarter of 2023 compared to approximately 38% of revenues in the third quarter of 2022 compared to approximately 17% of revenues in the third quarter of 2021.2022. For the first nine months of 2022,2023, the gross profit, expressed as a percentage of revenues, decreasedincreased to approximately 45%52% of revenues from product and other sales compared to approximately 51%45% of revenues from product and other sales in the first nine months of 2021. The increase2022.
Research and development expenses increased in gross profitthe third quarter of 2023 to $39,800 from product and other sales$23,900 in the third quarter of 2022 comparedand to the third quarter of 2021 is due primarily to higher ink shipments to the third party authorized printer used by two of our Company’s major licensees in the entertainment and toy products market. The decrease in gross profit from product and other sales$119,900 in the first nine months of 2022 compared to the first nine months of 2021 is due primarily to lower ink shipments to a third party authorized printers used by one of our Company’s major licensees in the entertainment and toy products market.
Research and development expenses decreased in the third quarter of 2022 to $23,9002023 from $44,000 in the third quarter of 2021 and to $95,900 in the first nine months of 2022 from $134,300 in the first nine months of 2021 due primarily to lowerhigher employee relatedand lab expenses in the third quarter and first nine months of 20222023 compared to the third quarter and first nine months of 2021.2022.
Sales and marketing expenses increaseddecreased to $71,200 in the third quarter of 2023 from $88,900 in the third quarter of 2022 and decreased to $88,900 from $56,900 in the third quarter of 2021. Sales and marketing expenses increased$218,600 in the first nine months of 2022 to2023 from $230,400 from $214,000 in the first nine months of 2021.2022. The increasedecrease in the third quarter of 2023 compared to the third quarter of 2022 is due primarily to higherlower commission expense onand employee related expenses in the higher levelthird quarter of sales2023 compared to the third quarter of 2022. The decrease in the first nine months of 2023 compared to the first nine months of 2022 is due primarily to lower commission and employee related expenses in the first nine months of 2023 compared to the first nine months of 2022.
General and administrative expenses increased to $833,800 in the third quarter of 2023 from $180,200 in the third quarter of 2022 and increased to $1,258,300 in the first nine months of 2023 from $964,600 in the first nine months of 2022. The increase in the third quarter and the first nine months of 20222023 compared to the third quarter and first nine, months of 2021.
General and administrative expenses increased in the third quarter and first nine months of 2022 to $180,200 and $964,600, respectively, from $122,300 and $385,500, respectively, in the third quarter and first nine months of 2021is due primarily to significantly higher professional fees, higher employee related expenses and higher insurance expenses offset by a decrease in professional fees and public company expense in the third quarter and first nine months of 2022 compared to the third quarter and first nine months of 2021.related expenses.
Income taxes in the third quarter and first nine months of 2021 resulted2023 include federal and state income taxes. The state income taxes result from limitations placed on income tax net operating loss deductions by the Commonwealth of Pennsylvania.
The net loss of $453,300 in the third quarter of 2023 compared to net income of $206,500 in the third quarter of 2022 compared to net income of $1,100 in the third quarter of 2021 resulted primarily from a higherlower gross profit on a higher level of licenses, royalties and fees offset in part by higher cost of revenues andproduct sales, higher operating expenses and interest income in the third quarter of 20222023 compared to the third quarter of 2021.2022. The net loss of $343,900 in the first nine months of 2023 compared to net loss of $293,900 in the first nine months of 2022 compared to netresulted primarily from a higher level of product sales and interest income of $158,400 in the first nine months of 2021 resulted primarily2023 compared to the first nine months of 2022, higher operating expenses in the first nine months of 2022 offset in part by a higher gross profit on a higher level of licenses, royalties and fees in the first nine months of 20222023 compared to the first nine months of 2021.2022.
Plan of Operation, Liquidity and Capital Resources
During the first nine months of 2022,2023, our Company’s cash increased to $5,355,700$10,476,500 at September 30, 20222023 from $1,846,700$5,337,800 at December 31, 2021.2022. During the first nine months of 2022,2023, our Company generated $9,800$167,200 from its operating activities, received $3,500,000 upon the sale of 2.5 million shares of its common stock and used $800$25,800 for capital expenditures.expenditures and generated $5,000,000 from the issuance of common stock.
During the first nine months of 2022,2023, our Company’s revenues increased approximately 7%15% primarily as a result of higher license and royalty revenues due primarilysales of ink to the five year license extension with onean authorized printer of our Company’s licensees in the entertainment and toy products market.
Additionally,market offset in part by lower royalty revenues from our Company’s licensees in the entertainment and toy products market. Our total overhead expenses increased in the first nine months of 20222023 to $1,290,900$1,596,800 compared to $733,800$1,290,900 in the first nine months of 2021.2022, our Company’s interest income increased and our Company’s income tax expense decreased in the first nine months of 2023 compared to the first nine months of 2022. As a result of these factors, our Company sustainedgenerated a net loss of $343,900 in the first nine months of 2023 compared to a net loss of $293,900 in the first nine months of 2022 compared to net income of $158,400 in the first nine months of 2021. Our Company’s total overhead expenses increased in the first nine months of 2022 compared to the first nine months of 2021 and our Company’s net interest income increased in the first nine months of 2022 compared to the first nine months of 2021.2022. Our Company had positive operating cash flow of $9,800$167,200 during the first nine months of 2022 and at2023. At September 30, 2022,2023, our Company had positive working capital of $6,420,000$11,538,600 and stockholders’ equity of $6,711,400.$13,474,500. For the full year of 2021,2022, our Company had net income of $49,400$1,813,100 and had positivenegative operating cash flow of $512,700.$8,100. At December 31, 2021,2022, our Company had working capital of $3,197,500$6,421,800 and stockholders’ equity of $3,505,300.$8,818,400.
In November 2018, our Company negotiated a $150,000 revolving line of credit (“Line of Credit”) with a bank to provide a source of working capital, if required. The Line of Credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The Line of Credit is subject to an annual review and quiet period. There have been no borrowings under the Line of Credit since its inception. We may need to obtain additional capital in the future to further support the working capital requirements associated with our existing revenue base and to develop new revenue sources. We cannot assure you that we will be successful in obtaining such additional capital, if needed. We continue to maintain a cost containment program including curtailment, where possible, of discretionary research and development and sales and marketing expenses.
Our plan of operation for the twelve months beginning with the date of this quarterly reportQuarterly Report consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships our Company has developed in the entertainment and toy products market. This includes two licensees that have been marketing products incorporating our Company’s technologies since 2012. These two licensees maintain a significant presence in the entertainment and toy products market and are well known and highly regarded participants in this market. We anticipate that these two licensees will expand their current offerings that incorporate our technologies and will introduce and market new products that will incorporate our technologies available to them under their license agreements with our Company. We will continue to develop various applications for these licensees. In October 2022, the Company completed an Amended and Restated License Agreement commencing in July 2023 with one of these two licensees that provides for a new five-year license term requiring minimum guaranteed royalty payments of no less than $520,000 each year of the term. We also plan to expand our licensee base in the entertainment and toy market. We currently have additional licensees marketing or developing products incorporating our technologies in certain geographic and niche markets of the overall entertainment and toy products market.
Our Company maintains its presence in the retail loss prevention market and believes that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. We will continue to adjust our production and technical staff as necessary and, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond our current capacity. Additionally, we will pursue opportunities to market our current technologies in specific security and non-security markets. There can be no assurancesWe cannot assure you that these efforts will enable our Company to generate additional revenues and positive cash flow.
Our future growth strategy includes expanding our business through acquisitions of other companies with competing or complementary services, technologies or businesses in order to expand our product and service offerings to grow our free cash flow. We are currently actively engaged in the process to identify acquisition candidates and negotiate transactions. As of the date of this report on Form 10-Q, we have no agreements to make any acquisition. We expect to fund our business expansion through the issuance of debt or equity securities, the payment of cash, the exchange of services, or any combination thereof.
Our Company has received, and may in the future seek, additional capital in the form of debt, equity or both, to support our working capital requirementsand to provide funding for other business opportunities. Beyond the Line of Credit, we cannot assure you that if we require additional capital, that we will be successful in obtaining such additional capital, or that such additional capital, if obtained, will enable our Company to generate additional revenues and positive cash flow.
As previously stated, we generate a significant portion of our total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. In the future, such sales may be adversely affected by changes in consumer spending that may occur as a result of an uncertain economic environment throughout the balance of 2022in 2023 and beyond due to any future effects of the ongoing COVID-19 pandemic and its effect on the global economy, geopolitical instability including the Russia-Ukraine war and the supply chain disruptions related to both as well as the record inflation and significantly higher interest rates currently being experienced in the United States along with the probability of an economic recession both in the United States and globally. As a result, our revenues, results of operations and liquidity may be further negatively impacted.impacted in future periods.
Contractual Obligations
As of September 30, 2022,2023, there were no material changes in our contractual obligations from those disclosed in our Annual Report on Form 10-K filed with the SEC on March 30, 2022,31, 2023, as amended on April 29, 2022,28, 2023, other than those appearing in the notes to the financial statements appearing elsewhere in this Quarterly Report on Form 10-Q.
Recently Adopted Accounting Pronouncements
As of September 30, 2022,2023, there were no recently adopted accounting standards that had a material effect on our Company’s financial statements.
15 |
Recently Issued Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. The amendments in this Update affect loans, debt securities, trade receivables, and any other financial assets that have the contractual right to receive cash. The ASU requires an entity to recognize expected credit losses rather than incurred losses for financial assets. For public entities, the amendments are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. ASU No. 2019-10 extends the effective dates for two years for smaller reporting companies and nonpublic companies.
In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The amendments in this Update affect entities that issue convertible instruments and/or contracts in an entity’s own equity. For convertible instruments, the instruments primarily affected are those issued with beneficial conversion features or cash conversion features because the accounting models for those specific features are removed. However, all entities that issue convertible instruments are affected by the amendments to the disclosure requirements in this Update. For contracts in an entity’s own equity, the contracts primarily affected are freestanding instruments and embedded features that are accounted for as derivatives under the current guidance because of failure to meet the settlement conditions of the derivatives scope exception related to certain requirements of the settlement assessment. The Board simplified the settlement assessment by removing the requirements (1) to consider whether the contract would be settled in registered shares, (2) to consider whether collateral is required to be posted, and (3) to assess shareholder rights. Those amendments also affect the assessment of whether an embedded conversion feature in a convertible instrument qualifies for the derivatives scope exception. Additionally, the amendments in this Update affect the diluted EPS calculation for instruments that may be settled in cash or shares and for convertible instruments. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Board decided to allow entities to adopt the guidance through either a modified retrospective method of transition or a fully retrospective method of transition.
Off-Balance Sheet Arrangements
Our Company does not have any off-balance sheet arrangements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.Risk
Not Applicable
Item 4. Controls and Procedures.Procedures
Evaluation of Disclosure Controls and Procedures. Our Company’s management, with the participation of our Company’s Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of September 30, 2022.2023. Based on this evaluation, our Company’s Principal Executive Officer and Principal Financial Officer concluded that, as of September 30, 2022,2023, our Company’s disclosure controls and procedures were effective, in that they provide reasonable assurance that information required to be disclosed by our Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to our Company’s management, including our Company’s Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting during the quarter ended September 30, 20222023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitation on Effectiveness of Controls. While our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance that their respective objectives will be met, we do not expect that our disclosure controls and procedures or our internal control over financial reporting are or will be capable of preventing or detecting all errors and all fraud. Any control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings.
None
Item 1A. Risk Factors.
Not applicable
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.Proceeds
None.
The shares of common stock were issued in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and by Rule 506 of Regulation D promulgated thereunder as a transaction by an issuer not involving any public offering.
Item 3. Defaults Upon Senior Securities.
None
Item 4. Mine Safety Disclosures.
Not applicable
Item 5. Other Information.Information
None During the quarter ended September 30, 2023, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.
Item 6. Exhibits.Exhibits
(a) Exhibits
The following exhibits are included herein:
Certification of Chief Executive Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | Filed herewith | |||
31.2 | Certification of Chief Financial Officer required by Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | Filed herewith | ||
32.1 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||
Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document | ||||
101.SCH | Inline XBRL Taxonomy Extension Schema | |||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | |||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | |||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | |||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | |||
104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 |
17 |
SIGNATURES
Pursuant to the requirementsrequirement of the Securities Exchange Act of 1934, the registrantour Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
NOCOPI TECHNOLOGIES, INC. | ||
DATE: November 14, | /s/ Michael | |
Michael | ||
Chairman of the Board | ||
DATE: November 14, | /s/ | |
18 |
EXHIBIT INDEX
19